Toolgen

Developer of Gene therapies by using CRISPR- Cas9

placeSeoul, Seoul, South Korea calendar_todayFounded 1999 groups81 employees language toolgen.com

Innovation

88 patent families (24 granted) — focus: Chemistry & metallurgy, Human necessities, Construction, Physics & computing; filing pace steady. Cited 5,923 times.

YearFilings
20153
20162
20176
201819
201916
202029
202122
202219
202332
202431
202528
20266

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Private equity120%
Other / undisclosed240%
Coming soon